Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 228120
                    [Title] => Once-daily PPI benefits many GERD patients
                    [Summary] => Positive results were achieved in terms of reducing healthcare costs and keeping patients asymptomatic in a recent testing of treatment guidelines for gastro-esophageal reflux disease. By following the guidelines which stipulate switching of gastroesophageal reflux disease (GERD) patients to single-dose proton pump inhibitors (PPIs) such as lansoprazole and omeprazole, researchers from the Department of Veterans Affairs Ann Arbor Healthcare System (VAAAHS), Michigan, found that medication costs dropped 53 percent, while 79.5 percent  of patients remained asymptomatic.
                    [DatePublished] => 2003-11-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

VAAAHS

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 228120
                    [Title] => Once-daily PPI benefits many GERD patients
                    [Summary] => Positive results were achieved in terms of reducing healthcare costs and keeping patients asymptomatic in a recent testing of treatment guidelines for gastro-esophageal reflux disease. By following the guidelines which stipulate switching of gastroesophageal reflux disease (GERD) patients to single-dose proton pump inhibitors (PPIs) such as lansoprazole and omeprazole, researchers from the Department of Veterans Affairs Ann Arbor Healthcare System (VAAAHS), Michigan, found that medication costs dropped 53 percent, while 79.5 percent  of patients remained asymptomatic.
                    [DatePublished] => 2003-11-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Once-daily PPI benefits many GERD patients

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | November 16, 2003 - 12:00am

Positive results were achieved in terms of reducing healthcare costs and keeping patients asymptomatic in a recent testing of treatment guidelines for gastro-esophageal reflux disease. By following the guidelines...

Opinion